re: Ann: Marketing authorisation for Recuvyra... Anyone intimate with the detail of the Lilly deal? Wondering if the royalty payments are qtrly or 6mthly. Would really like to know what the performance clauses that trigger the next big payment look like but know these have not been made public. Would like to think the strong growth of product sales already reported is getting us close. From memory the payments could total $194mill or there about. $1.16 earnings per share hmmm tasty.
- Forums
- ASX - By Stock
- ACR
- Ann: Marketing authorisation for Recuvyra granted
ACR
acrux limited
Add to My Watchlist
5.88%
!
1.6¢

Ann: Marketing authorisation for Recuvyra granted, page-10
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.6¢ |
Change
-0.001(5.88%) |
Mkt cap ! $6.524M |
Open | High | Low | Value | Volume |
1.7¢ | 1.7¢ | 1.5¢ | $19.90K | 1.210M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 463664 | 1.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 320000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 463664 | 0.015 |
2 | 320000 | 0.014 |
2 | 397000 | 0.013 |
1 | 80000 | 0.012 |
2 | 150000 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 320000 | 2 |
0.018 | 252359 | 2 |
0.019 | 677115 | 3 |
0.020 | 50000 | 1 |
0.021 | 203466 | 1 |
Last trade - 15.56pm 25/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |